Nurix Therapeutics, Inc. (NRIX)
16.32
+0.40
(+2.55%)
USD |
NASDAQ |
Apr 14, 16:00
16.32
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics EPS Diluted (Quarterly) : -0.792 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8824 |
| Stoke Therapeutics, Inc. | -0.9922 |
| Immunome, Inc. | -0.7516 |
| Gilead Sciences, Inc. | 1.742 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -87.17M |
| Revenue (Quarterly) | 6.252M |
| Total Expenses (Quarterly) | 93.43M |
| Enterprise Value | 1.163B |
| Gross Profit Margin (Quarterly) | 39.60% |
| Profit Margin (Quarterly) | -1.39K% |
| Earnings Yield | -19.37% |
| Normalized Earnings Yield | -19.37 |